对于凝血因子X抑制剂的可解释机器学习驱动的QSAR建模:从分子描述器到预测功效的分子描述器.
1Radiotherapy Department, Vocational School of Health Service, Akdeniz University, 07070, Antalya, Turkey. alionurkaya@akdeniz.edu.tr.
Journal of computer-aided molecular design
|January 22, 2026
概括
研究人员开发了一种机器学习模型,以预测小分子向凝血因子X (FXa) 的有效性. 这种可解释的QSAR框架有助于设计更安全,更有选择性的FXa抑制剂.
科学领域:
- 计算化学和化学信息学
- 药物发现和药物化学
背景情况:
- 凝血因子X (FXa) 抑制是一种经过验证的治疗方法.
- 在药物开发中,开发更安全,更有选择性的FXa抑制剂是一个重大挑战.
研究的目的:
- 使用机器学习创建一个可解释的定量结构-活动关系 (QSAR) 框架.
- 预测向FXa的小分子的抑制功效和活性类.
- 为了促进新型FXa抑制剂的合理设计.
主要方法:
- 针对FXa的6400种化合物的数据集是从ChEMBL中整理出来的.
- 化合物使用391个Mordred描述符进行了标准化和编码.
- 机器学习模型 (ExtraTreesRegressor,XGBoostClassifier) 用于回归和分类任务进行了基准测试.
- 用SHAP分析来确定模型的可解释性.
主要成果:
- 在一个独立的测试组中,ExtraTreesRegressor模型实现了R2=0.760和RMSE=0.831.
- 该XGBoostClassifier模型的准确度为0.91和ROC-AUC为0.962.9的准确度.
- SHAP分析确定了静电,拓和极地表面描述器作为FXa抑制的关键贡献者.
- 适用性领域评估证实了预测的可靠性.
结论:
- 开发的QSAR管道提供了强大的预测性能和机械解释性.
- 这种计算工具可以帮助虚拟选和设计新型FXa抑制剂.
- 该研究为开发更安全,更有选择性的FXa抑制剂提供了经过验证的框架.
关键词:
抗凝固药物发现的新发现适用性领域 适用性领域凝血因子X X凝血因子额外的树木回归器机器学习 机器学习分子描述器 分子描述器在QSAR建模中使用QSAR模型.在SHAP分析中,我们分析了SHAP.在XGBoostClassifier中,我们使用了XGBoostClassifier.在 pKi 预测预测.更多相关视频
相关概念视频
Predicting Molecular Geometry
45.5K
VSEPR Theory for Determination of Electron Pair Geometries
45.5K
Molecular Models
43.6K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
Coagulation
1.3K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.3K
Coagulation
9.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.8K
Molecular Factors Affecting Cell Division
3.9K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K


